Tie, J., Cohen, J. D., Wang, Y., Christie, M., Simons, K., Lee, M., . . . Gibbs, P. (2019). Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer. JAMA Oncol.
Chicago-stil citatTie, Jeanne, et al. "Circulating Tumor DNA Analyses As Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer." JAMA Oncol 2019.
MLA-referensTie, Jeanne, et al. "Circulating Tumor DNA Analyses As Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer." JAMA Oncol 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.